220 related articles for article (PubMed ID: 16197722)
1. New approaches to drug development in pediatric oncology.
Adamson PC; Blaney SM
Cancer J; 2005; 11(4):324-30. PubMed ID: 16197722
[TBL] [Abstract][Full Text] [Related]
2. Evolving paradigms for new agent development in pediatric oncology.
Flynn A; Fox E
Curr Opin Pediatr; 2018 Feb; 30(1):10-16. PubMed ID: 29176356
[TBL] [Abstract][Full Text] [Related]
3. Developing new agents for the treatment of childhood cancer.
Kurmasheva R; Morton C; Houghton PJ
Curr Opin Investig Drugs; 2005 Dec; 6(12):1215-27. PubMed ID: 16372407
[TBL] [Abstract][Full Text] [Related]
4. New approaches to therapeutic drug development for childhood cancers.
Campbell K; Ma C; DuBois SG
Curr Opin Pediatr; 2020 Feb; 32(1):35-40. PubMed ID: 31790026
[TBL] [Abstract][Full Text] [Related]
5. Clinical development of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors: what lessons have we learned?
Hidalgo M
Adv Exp Med Biol; 2008; 610():128-43. PubMed ID: 18593020
[No Abstract] [Full Text] [Related]
6. Tyrosine kinases as targets in cancer therapy - successes and failures.
Traxler P
Expert Opin Ther Targets; 2003 Apr; 7(2):215-34. PubMed ID: 12667099
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary management of childhood brain tumors: a review of outcomes, recent advances, and challenges.
Pollack IF
J Neurosurg Pediatr; 2011 Aug; 8(2):135-48. PubMed ID: 21806354
[TBL] [Abstract][Full Text] [Related]
8. Targeted drugs in oncology: new names, new mechanisms, new paradigm.
Rotea W; Saad ED
Am J Health Syst Pharm; 2003 Jun; 60(12):1233-43; quiz 1244-5. PubMed ID: 12845919
[TBL] [Abstract][Full Text] [Related]
9. Precision medicine in pediatric oncology.
Forrest SJ; Geoerger B; Janeway KA
Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
[TBL] [Abstract][Full Text] [Related]
10. Landscape of early clinical trials for childhood and adolescence cancer in Spain.
Bautista F; Gallego S; Cañete A; Mora J; Diaz de Heredia C; Cruz O; Fernández JM; Rives S; Madero L; Castel V; Cela ME; Ramírez G; Sábado C; Acha T; Astigarraga I; Sastre A; Muñoz A; Guibelalde M; Moreno L
Clin Transl Oncol; 2016 Jul; 18(7):708-13. PubMed ID: 26489424
[TBL] [Abstract][Full Text] [Related]
11. Pediatric oncology: current views and outcomes.
Reaman GH
Pediatr Clin North Am; 2002 Dec; 49(6):1305-18, vii. PubMed ID: 12580367
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
[TBL] [Abstract][Full Text] [Related]
13. Optimising translational oncology in clinical practice: strategies to accelerate progress in drug development.
Stahel R; Bogaerts J; Ciardiello F; de Ruysscher D; Dubsky P; Ducreux M; Finn S; Laurent-Puig P; Peters S; Piccart M; Smit E; Sotiriou C; Tejpar S; Van Cutsem E; Tabernero J
Cancer Treat Rev; 2015 Feb; 41(2):129-35. PubMed ID: 25533737
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics in cancer drug discovery and development: inhibitors of the Hsp90 molecular chaperone.
Workman P
Cancer Detect Prev; 2002; 26(6):405-10. PubMed ID: 12507224
[TBL] [Abstract][Full Text] [Related]
15. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
16. [New concepts in human oncology: is it possible to use them in veterinary medicine as well?].
Marconato L; Ruess-Melzer K; Buchholz J; Kaser-Hotz B
Schweiz Arch Tierheilkd; 2011 Aug; 153(8):351-60. PubMed ID: 21780063
[TBL] [Abstract][Full Text] [Related]
17. New targets and targeted drugs for the treatment of cancer: an outlook to pediatric oncology.
Rossig C; Juergens H; Berdel WE
Pediatr Hematol Oncol; 2011 Oct; 28(7):539-55. PubMed ID: 21936619
[TBL] [Abstract][Full Text] [Related]
18. Imatinib as a paradigm of targeted therapies.
Druker BJ
Adv Cancer Res; 2004; 91():1-30. PubMed ID: 15327887
[TBL] [Abstract][Full Text] [Related]
19. [Cancer chemotherapy; past, present and future--from the aspect of fundamental studies].
Tukagoshi S
Gan To Kagaku Ryoho; 2003 Oct; 30(10):1398-403. PubMed ID: 14584271
[TBL] [Abstract][Full Text] [Related]
20. Pediatric neuro-oncology: current status and future directions.
Heath JA; Zacharoulis S; Kieran MW
Asia Pac J Clin Oncol; 2012 Sep; 8(3):223-31. PubMed ID: 22897924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
